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A B S T R A C T
Frailty, a consequence of the interaction of the aging process and certain chronic diseases, compromises func-
tional outcomes in the elderly and substantially increases their risk for developing disabilities and other adverse
outcomes. Frailty follows from the combination of several impaired physiological mechanisms affecting multiple
organs and systems. And, though frailty and sarcopenia are related, they are two different conditions. Thus,
strategies to preserve or improve functional status should consider systemic function in addition to muscle
conditioning. Physical activity/exercise is considered one of the main strategies to counteract frailty-related
physical impairment in the elderly. Exercise reduces age-related oxidative damage and chronic inflammation,
increases autophagy, and improves mitochondrial function, myokine profile, insulin-like growth factor-1 (IGF-1)
signaling pathway, and insulin sensitivity. Exercise interventions target resistance (strength and power), aerobic,
balance, and flexibility work. Each type improves different aspects of physical functioning, though they could be
combined according to need and prescribed as a multicomponent intervention. Therefore, exercise intervention
programs should be prescribed based on an individual's physical functioning and adapted to the ensuing re-
sponse.
1. Introduction
Increasing numbers of people reaching the ranks of the elderly is
one of the achievements of the past century. Whereas the early years of
the 20th Century saw a life expectancy of about 30 years, this statistic
had more than doubled worlwide by the end of the century [1]. Further,
this trend will continue at least until the middle of the current century.
In 2015, there were 617 million people of the age of 65 or older, and the
next 35 years will see a massive increase in the percentage of older
people. The fastest growing age group will be those over the age of 80,
reaching 447 million individuals by 2050, three times the current
number [2]. Based on these predictions, millions of people will endure
the aging process, with variations depending upon cultural and socio-
economic conditions [3].
The aging process is a somewhat more complex issue than just the
passing of time. Aging is characterized by several highly prevalent
changes, including an increase in morbidity and a decrease in func-
tional performance which, although linked, are two separate conditions
[4,5]. In fact, as we age, functioning increasingly becomes the factor
most strongly associated with quality of life and the risk for several
adverse outcomes, including hospitalization, permanent
institutionalization, use of health and social resources, and death [6].
In 2015, the World Health Organisation (WHO) released its first
report on aging and health [7] in which it recognized the true relevance
of function, the components involved in its preservation or deteriora-
tion, and how the relationship between what I am able to do and the
challenges of the environment mark the presence of functional au-
tonomy or disability. In that report, WHO defines healthy aging as “the
process of developing and maintaining the functional ability that en-
ables wellbeing in older ages.” According to this definition, older
people with multiple diseases may enjoy a healthy aging process if they
maintain functional ability, i.e., elderly's health status is defined by
functional status rather than morbidity. This stance is a true milestone
not only in its conception of health with its theoretical consequences
but also in its approach to health, with its practical consequences [8,9].
The impact of the latter ones on the elderly is extremely important, as
the possibility of prolonging life is dramatically reduced [10] and the
potential for improving the quality of life reaches its maximal re-
levance.
Which factors are associated with function and, secondly, linked to
personal autonomy? WHO (2015) distinguishes between two types of
factors. The first type falls under what is called intrinsic capacity and the
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second type is environment. Intrinsic capacity is defined as “the com-
posite of all the physical and mental capacities an individual can draw
on” and is the final outcome caused by the joint effect of genetic
background, chronic diseases, lifestyles, changes due to aging and
broader geriatric syndromes.
Thus, in a stable environment, function is mainly determined by
intrinsic capacity. However, intrinsic capacity starts declining at a quite
constant rate (1% per year) as soon as the maturity process is completed
(in human beings, around 20–25 years of age) [11]. When this declining
intrinsic capacity reaches a certain threshold, challenges derived from
the environment are no longer possible to be overcome and disability
appears (Fig.1). Hence, in older people the transition from a robust
state to disability is a long-lasting, continuous process which may take
years [12]. Meanwhile, as intrinsic capacity declines an associated
component also decreases: functional reserve (Fig. 2). Functional re-
serve is essential, among other reasons, to avoid stressors impacting
function and, if impacted, to recover the affected function. Conse-
quently, when intrinsic capacity and functional reserve are under
minimums, the risk for additional disability is very high and the pos-
sibility of recovery is very low. This conceptual framework should in-
clude a stage in the pathway from robustness to disability where the
intrinsic capacity is low, but still above the disability threshold, and the
functional reserve is reduced, but still enough for total or partial
function recovery. This stage in the pathway, characterized by high
susceptibility to low power stressors and high risk for adverse outcomes
(e.g., disability and its associated consequences like hospitalization,
institutionalization, or death) while still maintaining potential for re-
covery, is what it is referred to as frailty [13–15].
Fig. 1. Three different trajectories of intrinsic capacity along the lifetime: Accelerated aging, usual aging, and successful/healthy aging. Trajectories are suitable for
intervention, acting on the rate of decrease in intrinsic capacity.
Fig. 2. Shortening of intrinsic capacity and functional reserve leading to frailty and, if no intervention, to disability and death. As these shortages progress, the
likelihood of reversing functional impairment decreases. When the threshold for disability is crossed, the possibility of restoring robustness is uncertain.
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Prevention or delay of functional status decline, progression to
disability, with its characteristic loss of personal self-sufficiency has
been one of the main classical but also ongoing objectives of geriatric
medicine [6,16–18]. Therefore, in the past decades frailty has received
increasing attention as a window of opportunity to avoid or postpone
disability. Frailty has been examined using two different approaches
[15]. One of them, measuring deficit accumulation generates a frailty
index; the other one is defining a particular phenotype (the frailty
phenotype), which denotes the underlying processes where the effects
of the aging process, subclinical and clinical diseases merge (Fig. 3).
The frailty phenotype also captures the mechanisms shared by the aging
process and certain chronic diseases which affect several organs and
systems. These mechanisms are then phenotypically expressed as
functional deterioration, including frailty [19]. By either approach, the
roads leading to frailty are varied, with different trajectories and rates
[20].
Increasing evidence reports the benefits yielded by exercise and
multimodal interventions on the functional status of older people, in-
cluding frailty. Data clearly support early intervention in the pathway
from robustness to disability in order to maximize potential benefits
[21,22]. This evidence has fostered the assessment of pre-disability
conditions, i.e., when individuals are still independent but their per-
formance (as an indicator of the risk for developing disability) is im-
paired, as it is the case in frailty. Although there are over 50 frailty
assessment tools, for the purpose of this review we will use the Frailty
Phenotype as designed by Fried and colleagues and its three categories.
The Frailty Phenotype evaluates five health- and function-related do-
mains and classifies people into three categories accordingly: Robust (0
domains affected), pre-frail (1–2) and frail (≥3) [13].
This review has four main aims. First, to provide data and describe
the mechanisms involved in frailty which emerge from the aging pro-
cess itself and/or chronic diseases affecting certain organs and systems.
Second, to show how physical activity and exercise hinder some of
those harmful mechanisms, thus improving physical function and de-
laying or reversing frailty. Third, to analyse the individual components
of the physical exercise programs and their best implementation to
abate frailty. And, finally, to analyse current evidence and bases for
designing, implementing, and evaluating a program of physical exercise
for older frail people.
2. Pathophysiology of frailty
Frailty is a clinical syndrome that affects multiple key systems in-
cluding the endocrine, respiratory, and cardiovascular systems as well
as the skeletal muscle. This syndrome often marks the onset of the
process known as “Cycle of Frailty” which leads to sarcopenia and other
multisystemic failures [23] (Fig. 4). Close knowledge on how the aging
process interacts with chronic diseases to impair organic systems
function and bring about frailty is key for designing successful pre-
ventative strategies.
2.1. Skeletal muscle
Evidence clearly establishes an association between frailty and the
structure and function of skeletal muscle. However, although sarco-
penia is one of the key risk factors for frailty syndrome, frailty and
sarcopenia are distinct conditions [24]. In fact, muscle alterations are
detected only in, approximately, 2/3 of frail individuals. This suggests
that the frailty phenotype, albeit influenced by skeletal muscle func-
tion, is a clinical manifestation of a multisystemic functional impair-
ment [25].
Originally conceptualized as the age-related loss of skeletal muscle
mass, the concept of sarcopenia has evolved to stand for the decline of
muscle mass and function among older adults [26]. In addition, the
aging process compromises both muscle structure and function. The
reduction in muscle mass causes an increase in the proportion of
maximal power generating capacity of the remaining muscles per-
forming the activities of daily living. This, let's say, overuse of the re-
maining muscles, leads to an earlier onset of fatigue which, in turn,
hastens the shift from an independent to a dependent lifestyle [27].
Lean muscle mass suffers a considerable decline with age. On
average, it makes up 50% of total body weight in young adults versus
about 25% in 70 to 80 year-olds [28]. This decline, especially that of
the lower limb, impacts mobility status significantly. Further, age-re-
lated muscle mass loss has been associated to a state of “anabolic re-
sistance” where there is an imbalance of muscle protein synthesis and
breakdown processes in response to stimuli, like exercise or nutrition
[29]. In fact, reduced rates of cumulative muscle protein synthesis ac-
companied by blunted mass gains were observed in older adults in re-
sponse to resistance exercise training when compared to young adults
[30,31]. Both cross-sectional and longitudinal studies of older adults of
Fig. 3. The spectrum of intrinsic capacity from the
perspectives of organ and systemic level, and their
clinical manifestations. In the first stages, there
are changes in isolated organs that can still be
reversed and do not impact function due to a high
functional reserve. As the condition progresses,
other organs start to deteriorate, due to the aging
processes or to the accumulation of chronic dis-
eases sharing similar mechanisms of damage. At
this stage frailty status appears: there is still en-
ough functional reserve to maintain functional
autonomy, although some deterioration in per-
formance-based tasks can be observed if carefully
assessed. If the condition continues progressing,
functional reserve is depleted and disability takes
hold, with few chances for recovery.
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both genders place the onset of age-related decline in muscle strength
on the third or fourth decade of life [32–35]. However, longitudinal
studies reveal that muscle mass loss does not fully account for the loss
of muscle strength and physical function in older adults [36,37]. In fact,
muscle strength is lost much more rapidly than the concomitant muscle
mass [38,39]. Thus, muscle strength, the best single measure of age-
related muscle changes, is associated with physical disability in in-
strumental activities of daily living and functional limitation [40].
Additionally, changes in muscle quality (force corrected for size)
also take place during aging [41,42]. Muscle power declines earlier and
faster with age than strength does [43]. And, unfortunately, muscle
power seems to have a stronger association to functional capacity
among frail elderly populations than muscle strength [44].
Other authors have reported that age-related muscle power loss may
be impacted by a reduced number of motor units, with the denervation
of muscle preceding the loss of muscle axons and consecutively motor
unit death [45,46]. As a compensatory mechanism, adjacent healthy
motor neurons (often type I) reinnervate the denervated muscle fibers
(often type II) through terminal axonal sprouting [47]. However, as this
mechanism turns defective as we age, it actually triggers muscle loss by
increasing myocytes apoptotic potential due to the loss of trophic fac-
tors [48]. It has been suggested that age-related changes in the grip and
leg extensor strength are not primarily due to muscle atrophy but are
reflective of declines in the integrity of the nervous system [26]. In-
terestingly, well-trained seniors who had exercised regularly in the
previous 30 years had two advantages over healthy sedentary age-
matched seniors; first, they had retained a greater maximal muscle
force and function and, second, they had preserved muscle fibers size
resulting from fiber rescue by reinnervation [49].
Further, research on satellite cells (SCs) reveals more potential links
between exercise, physical functioning, and muscle health. SCs re-
present a population of muscle stem cells that reside within muscle
tissues in defined niches and promote skeletal muscle repair [50].
Proliferation and differentiation of SCs during muscle regeneration is
profoundly influenced by innervation, vasculature, hormones, nutri-
tion, and the extent of tissue damage [51]. SCs may also play an im-
portant role in muscle maintenance and muscle growth in response to
resistance exercise training [52]. Compared to younger muscle, aged
muscle contains fewer SCs and a higher proportion of them display
impaired proliferative capacity and regenerative potential, which may
explain muscle's failure to regenerate successfully [53] and the inability
to maintain its mass [52]. Fortunately, even though SCs density in type
II muscle fibers and the size of the fibers themselves declined with age,
both magnitudes increased after resistance exercise training for 12
weeks [54]. However, despite reports of a clear correlation between age
and impaired regenerative potential of SCs, conflicting results arising
from animal models [55,56] keep the debate on the contribution of SCs
to sarcopenia alive.
Authors have reported that muscle function alterations not only
contribute to an individual's frailty status, but that reduced muscle
strength, as measured by grip strength, is associated with an increased
risk of mortality [57,58]. Recently, grip strength has revealed as a
strong predictor of cardiovascular mortality and a moderately strong
predictor of incident cardiovascular disease. These findings suggest
muscle strength as a risk factor for incident cardiovascular disease and
as a predictor of overall mortality [59]. In addition, regional muscle
strength was shown as a predictor of medium-term mortality and hos-
pitalization in older men and women [60].
2.2. Respiratory system
Pulmonary function also declines progressively with aging [61] due
to fewer alveoli and capillaries or reduced diffusing capacity and in-
creased residual volumes among other factors [62]. In addition, in-
creased stiffness of chest wall combined with reduced respiratory
muscle strength result in a shrunk forced expiratory volume [62]. These
lung changes may, in turn, further contribute to loss in muscle strength
and power as well as mobility. Further, the reverse has also been sug-
gested, i.e., that the decline in muscle strength may lead to reduced
pulmonary function, low physical performance, and mobility disability
[63]. Although cross-sectional, a study in healthy older adults suggests
that decline in mobility with aging may be due to a drop in both muscle
strength and power and also mediated by decreases in spirometric
pulmonary function [64]. In this sense, by limiting energy supply, les-
sened pulmonary function could result in impaired leg strength, con-
tributing to the development of mobility disability [65]. Nevertheless,
the observed association between mobility disability incidence, loss of
ability to ambulate and pulmonary function in the elderly was rela-
tively independent of respiratory muscle strength and leg strength. This
suggests that physical activity and pulmonary function seem to con-
tribute to the development of mobility disability through mechanisms
other than the already known effects on muscle strength [66].
Findings regarding how frailty and exercise capacity were related to
pulmonary function in community-dwelling disabled older women
support the significance of respiratory function in physical perfor-
mance. Further, the beneficial effects of pulmonary function on exercise
capacity were only significant in the absence of frailty [67]. Along these
lines, we may expect pulmonary/respiratory diseases to precipitate
frailty and mobility disability. Supporting this idea, a higher frailty
index was observed in a large sample of patients with chronic ob-
structive pulmonary disease (COPD) [68]. And indeed, a recent meta-
analysis of observational studies concluded that older participants with
COPD had a two-fold increased risk for frailty [69]. COPD patients
exhibited lower physical function [70] and the risk for frailty with
mobility disability increased in COPD patients as the disease grew in
Fig. 4. Aging together with increase in oxidative damage and chronic in-
flammation represent three interrelated age-dependent processes that provide a
background prone to organic systems dysfunction and age-related chronic
diseases. The interaction between age-related chronic diseases, aging process,
oxidative stress, and inflammation may lead to multisystem dysfunction and
frailty phenotype in the elderly.
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severity [71]. In fact, COPD was revealed as a main risk factor for frailty
in a large sample of middle-aged and older subjects [72].
Finally, frailty has been reported as an independent predictor of all-
cause mortality in patients with interstitial lung disease referred for
lung transplantation [73] as well as associated with incident and
longer-duration hospitalization and poor quality of life in COPD pa-
tients [74]. In fact, it has been proposed that frailty is an independent
risk factor for the development and progression of COPD and, in turn,
evidence supports that COPD can lead to frailty [75]. In fact, long-
itudinal studies have reported that the association between frailty and
COPD is, indeed, bidirectional [76].
2.3. Cardiovascular system
The incidence and severity of subclinical and clinical manifestations
of cardiovascular diseases (CVD) increase steeply with advanced age
[77,78] even in the absence of traditional risk factors [79]. That is, even
after accounting for the higher prevalence of cardiovascular risk factors
in older people, the aging process, by its own nature, independently
worsens cardiovascular health [80]. The impact of the passing of time
on structure and function of the cardiovascular system leads not only to
cardiovascular events and strokes, but also to frailty, functional decline,
and cognitive impairment [81]. Aging-related alterations involve the
endothelium, vascular smooth muscle cells, as well as the extracellular
matrix of vessel wall [82,83]. Intima-media thickening (IMT), increased
arterial stiffness, and dilation of central elastic arteries are key aspects
of age-associated changes in vasculature resulting in reduced ability to
expand and contract in response to pressure variations [84]. Further,
reduced thigh muscle cross-sectional area as an indicator of sarcopenia
was associated with increased carotid IMT and pulse wave velocity
(PWV) as a measure of arterial stiffness in middle-aged to elderly men.
Conversely, thigh skeletal muscle cross-sectional area was reported as
an independent determinant of PWV, suggesting that sarcopenia and
atherosclerosis may interact with each other [85].
As it is known, increased arterial stiffness is related to advanced age
[86]. And, it has been proposed to contribute to the association be-
tween sarcopenia and cognitive impairment [87]. Furthermore, cross-
sectional studies in community-dwelling older adults confirmed that
frailty was associated with arterial stiffness [88,89]. Based on data from
a sample of patients in a Chinese Hospital, frailty was also shown to be
associated with increased carotid IMT as well as with arterial stiffness
measured as cardio-ankle vascular index (CAVI). Likewise, CAVI was
higher in the frail group than in the pre-frail or robust groups and was
inversely correlated with grip strength and walking speed [90].
Arterial stiffness is linked to endothelial dysfunction as suggested by
the impairment of endothelial vasodilation that always precedes ar-
terial stiffness [91]. Endothelial dysfunction, manifested by a reduction
of the endothelium-dependent vasodilation, is associated with the aging
process in both the micro- and the macrovasculature of animal models
[92] and humans [82,93,94]. Endothelial dysfunction plays a key role
in the onset and persistence of atherosclerosis, and as an independent
predictor of cardiovascular events [95]. Endothelial function is related
to physical performance as indicated by the significant relationship
between brachial artery flow-mediated dilation (FMD) and physical
function in elderly men [96]. Indeed, the impairment of endothelial
vasodilation induced by insulin in older adults relates to the defective
anabolism of muscle proteins driven by this hormone in skeletal muscle
[97]. In addition, the levels of asymmetric dimethylarginine (ADMA), a
marker of endothelial dysfunction, increase the risk of frailty in older
adults free of atherosclerotic disease [98]. Moreover, frailty was asso-
ciated with worse endothelial function and mortality in patients with
chronic kidney disease [99].
Along similar lines, the role of vascular health in motor function is
supported by longitudinal studies results reporting associations be-
tween elevated cardiovascular risk in early midlife and poor motor
function later in life [100]. In addition, carotid IMT at baseline was
associated with lower isometric handgrip strength at follow-up in older
men [101]. Also, cardiovascular risk scores at baseline in a cohort of
CVD-free 45-69 year-olds were associated with future risk of incident
frailty by the10-year follow-up [102]. A recent study in 392 older
participants reported that those with CVD were more likely to experi-
ence a rapid functional decline than their CVD-free counterparts [103].
Thus, poor cardiovascular function in the elderly likely contributes
to the onset of frailty but the relationship between CVD and frailty is
likely bidirectional [104] as frailty is an adverse prognostic factor in
cardiac patients [105]. Frailty and pre-frailty were associated cross-
sectionally with higher risk of CVD and longitudinal studies concluded
that pre-frailty and frailty increased the risk for incident CVD in 23%
and 70%, respectively [106]. In fact, data from 2,825 participants aged
70–79 and residing in the USA showed that moderate and severe frailty
were associated with increased incidence of heart failure [107]. And,
similarly, pre-frailty and frailty were associated with higher risk of CVD
in Italian older people who enjoyed no limitations in activities of daily
living [108]. Finally, frailty increased the risk for CVD development
independently from early atherosclerosis markers [106]. Among spe-
cific frailty domains, exhaustion, low physical activity, slow gait speed,
and weak grip strength have been associated with increased risk for
incident CVD [109–111]. Recent work concludes that frailty and CVD
share main risk factors as well as oxidative stress and inflammatory
background [105,112,113]. Thus, physical exercise represents an effi-
cacious strategy for improving both conditions [114]. This supports the
stance that both conditions are bidirectionally related as they both also
uniquely contribute to unsuccessful aging, while not eliminating the
possibility of being separate manifestations of an underlying common
physiological pathology.
2.4. Endocrine system/metabolic diseases
Sex hormones decline progressively with age among healthy, non-
obese men starting in their 30s whereas the sex hormone binding glo-
bulin (SHBG) increases during their 50s and beyond [115]. The com-
bination of these two changes leads to a steep decrease in free testos-
terone levels in aging men [116–118]. Decline in androgen levels has
been postulated as a potential mechanism contributing to frailty. In
Spanish men aged ≥65 years, lower free and total testosterone serum
levels were associated with frailty [119] supporting previous findings
[120–122]. A significant increase in the risk for frailty was detected in
men with SHBG serum concentrations ≥66 nmol/L or with free tes-
tosterone levels< 243 pmol/L [123]. Moreover, prospective studies
have shown that low levels of testosterone predict frailty onset or
progression in men [120,122]. Although scarce, a handful of studies
have also analysed the association of testosterone and frailty in women.
In women aged 70–79 years of age, two or three deficiencies in hor-
monal levels of insulin-like growth factor 1 (IGF-1), free testosterone, or
dihydroepiandrosterone sulphate (DHEAS) greatly increased the like-
lihood of being frail [124]. Older women presenting 4 or more Fried’s
criteria for frailty displayed very low levels of free testosterone, al-
though this association appeared confined to obese women [119]. De-
spite the clear relationship between low androgen levels and frailty,
data provided by testosterone supplementation studies in older adults
are not consistent. A recent review concluded that whereas testosterone
modestly improves lean muscle mass in older men regardless of frailty
status, the hormone's effect on physical function is weak [125]. How-
ever, more recent findings suggest that testosterone supplementation
may facilitate the molecular changes produced by exercise in skeletal
muscle so as to actually enhance resistance training's benefit on phy-
sical function [126].
Diabetes mellitus (DM), predominantly type 2 diabetes, is one of the
most prevalent chronic diseases in older adults [127]. There is a clear
relationship between diabetes and frailty [128] and the relationship
seems to be bidirectional [129]. In fact, frailty and sarcopenia are
emerging as new complications leading to disability in addition to
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traditional micro and macrovascular diseases [130]. In a cross-sectional
study conducted in primary health care settings, older adults (65–74
years) with diabetes were more likely to perform poorly in physical
tasks than their DM-free peers [131]. Longitudinal studies have re-
ported that DM increases the risk for frailty in older adults (60 years or
more) [132]. Multivariate analyses carried out in older diabetic parti-
cipant data concluded that physical frailty was independently asso-
ciated with a higher disability and mortality, suggesting that frailty in
this population is an unfavorable and important prognostic factor
[133,134]. The co-ocurrance of diabetes and frailty in older people is
not surprising since these two age-related conditions share common
underlying pathophysiological mechanisms. These mechanisms involve
imbalances in endocrine, neurohormonal, vascular, and muscular
function among others. The conditions also share key risk factors in-
cluding impaired insulin resistance, glucose dysregulation, physical
inactivity, and obesity [19].
In addition to the associated comorbidities, diabetes directly im-
pacts skeletal muscle thus contributing to mobility reduction in older
individuals [28]. The association of diabetes with low gait speed is
potentially mediated by impaired muscle function [135]. In fact, loss of
muscle mass and/or strength is greater in long-lasting diabetes or
higher HbA1C, and the loss is attenuated by insulin sensitizers
[28,136,137]. Muscle strength measured via handgrip test was in-
versely associated with fasting glucose, HbA1c, fasting insulin as well as
with insulin resistance as determined by homeostasis model assessment
of insulin resistance (HOMA) score [138]. Longitudinal study results
concluded that older patients with diabetes and HbA1C level ≥8.5%
had a higher risk of low muscle quality and performance status than
control non-diabetic peers [139].
In addition to diabetes, other related metabolic alterations have
been proposed to have influence on physical function in the elderly. For
instance, metabolic syndrome [140] has been linked to an increased
risk of frailty [141–143], but not in all studies [144]. On the other
hand, among adults over 50, frail ones were more likely to have me-
tabolic syndrome than the non-frail [145]. In a USA population, me-
tabolic syndrome was correlated with frailty index in younger (≤65)
and older subjects (> 65), although the association was weaker in the
latter. Frailty, but not metabolic syndrome, predicted mortality in both
age groups [146], suggesting that the previously reported association of
metabolic syndrome with mortality may have been influenced by the
failure to adjust for frailty.
Insulin resistance seems to play a key role in the pathophysiological
process underlying functional impairment related to diabetes in the
elderly, even before the onset of diabetes. Supporting this, an inverse
association was detected between quadriceps strength and insulin re-
sistance in non-diabetic individuals 70 years and over [147]. Low in-
sulin sensitivity has been associated with low lean muscle mass [148].
In fact, a positive association between HOMA-IR level and frailty in
elderly adults has been recently reported whereas this association failed
to reach significance in middle-aged participants. In this study, among
the frailty components, weakness, exhaustion, and low physical activity
were related to insulin resistance [149].
The direct impact of insulin resistance on skeletal muscle could
explain the deterioration of physical function related to this condition
[150]. In fact, altered muscle fiber type content and an increased ac-
cumulation of intramyocellular lipid droplets have been observed in
muscle biopsies from older subjects with metabolic syndrome [151]. In
this sense, non-diabetic insulin resistance exarcebates the decline in
protein anabolic response in older adults and the decline only worsens
in the presence of diabetes when glucose metabolism is further im-
paired [152].
Diabetes impacts vascular function in older adults. This is supported
by the fact that heat-induced skin vasodilation was further impaired in
the presence of type 2 diabetes in older subjects compared to their non-
diabetic and younger counterparts [153], suggesting that, the impact of
diabetes and aging on vascular function may be additive. Thus,
evidence from epidemiological and functional studies strongly suggests
that the co-presence of older age and diabetes increases vascular im-
pairment to a greater extent than either condition separately. Although
the underlying mechanisms are not fully understood, inflammation has
been pointed out as a key factor in the exacerbated vascular damage
produced when older age and diabetes coexist [154].
Additionally, diabetes and insulin resistance may interfere with
other systemic functions that influence the risk of frailty. Hormonal
alterations may represent one of them. In this sense, reduced plasma
levels of free and total testosterone have been observed in men with
type 2 diabetes and the prevalence of testosterone deficiency syndrome
in type 2 diabetic patients is estimated at around one third [155–159].
The hormonal impact of diabetes was suggested to be sex specific since
lower levels of testosterone were confirmed in diabetic men but not
women [160]. Interestingly, low testosterone levels are associated with
insulin resistance in both diabetic and non-diabetic men [161–163]. In
contrast, insulin resistance is associated with increased levels of tes-
tosterone in women [161,164]. However, in both men and women,
circulating sex hormone binding globulin (SHBG) is reduced in the
presence of diabetes, inversely related to insulin resistance and predicts
glucose intolerance [160,162,164,165].
3. Age-Related signaling pathways involved in physical
dysfunction and frailty and its modulation by physical exercise/
activty
Physical activity is known to preserve or improve the function of
multiple key systems affected by age, including the endocrine, re-
spiratory, and cardiovascular systems as well as skeletal muscle.
Understanding the pathways through which exercise impacts physical
function is important as it might facilitate the development of new
therapeutic strategies to improve performance in the aged population
and to prevent and reverse frailty. Below we discuss the most common
age-related signaling pathways involved in physical dysfunction and
how they are modulated by exercise (Fig. 5).
3.1. Oxidative stress
The impact of oxidative stress on the functioning of different sys-
tems, tissues, and organs has been suggested as the main underlying
link between aging and its associated chronic diseases and frailty [166].
In fact, both frailty and age-related chronic diseases were related to a
common underlying oxidative damage [19].
Oxidative stress results from the imbalance between pro and anti-
oxidant species. It is widely accepted that adequate efficiency of anti-
oxidant response is compromised during aging [166]. The stimulation
of transcription factor nuclear erythroid-2 like factor-2 (Nrf2)/anti-
oxidant response element (ARE) pathway seems to play a prominent
role in response to oxidative insult in order to induce antioxidant de-
fense. Studies in rodents demonstrated that aging is associated with
decreased expression of Nrf2 in skeletal muscle which is related to
frailty phenotype in these animals [167]. In fact, Nrf2 deficiency ex-
acerbates age-related unfavorable outcomes regarding loss of muscle
mass and physical function together with increased oxidative stress and
mitochondrial dysfunction [167–169]. Based on this evidence, it has
been postulated that the defect in the Nrf2-mediated signaling during
aging contributes to manifestation of chronic age-related diseases in-
cluding frailty [19]. The observed association between frailty pheno-
type, reduced systemic mRNA expression of Nrf2, and three of its target
genes (heme oxygenase-2, thioredoxin reductase-1 and superoxide
dismutase-2) in community-dwelling older adults supports this hy-
pothesis [170].
Despite their well-known deleterious role, ROS are key mediators in
exercising muscle exerting an adaptive response that involves tran-
scription of redox-sensitive factors which, in turn, promote the increase
in cytoprotective proteins such as catalase, superoxide dismutases, and
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heat shock proteins that prevent oxidative damage. This response to
ROS generation is severely diminished in aged muscle [171].
Although previous studies failed to demonstrate a reduction of
oxidative stress with exercise in the elderly [172] despite improvement
in their overall health condition [173], anti-oxidative effects of exercise
training are widely accepted. But not all types of exercise produce the
same effects. Single bouts of exercise exceeding certain intensity and
duration have been shown to transiently increase ROS from the mi-
tochondria and other oxidases which may actually harm the cell [174].
In contrast, chronic exercise showed benefits by attenuating age-related
oxidative stress in different organs including skeletal muscle [175], and
arteries [176] in animal models. Furthermore, muscle biopsies from
lifelong trained older subjects showed decreased oxidative stress and
increased catalase expression when compared to the untrained group
[174]. In fact, increased antioxidant status has been closely related to
age-associated skeletal muscle changes improvement [177].
Compared to a sedentary group, trained elderly presented lower
plasmatic concentrations of oxidized LDL (marker of oxidative stress)
and decreased expression of genes involved in oxidant production
evaluated in peripheral blood mononuclear cells [178]. A recent study
observed how 12-week exercise training produced a reduction in plas-
matic levels of protein carbonylation in older subjects with COPD.
Moreover, protein carbonylation was associated with variations in
muscle size and pennation angle as well as with exercise-induced
structural and functional adaptations [179]. Furthermore, Mota and
collaborators reported the effectiveness of a combined exercise program
in reducing oxidative stress including DNA damage and increased an-
tioxidant capacity in women over 40, regardless of age, suggesting that
physical exercise may help mitigate the aging processes associated with
oxidative stress [180]. Supporting this work, Cobley and colleagues
reported an attenuation of age-related macromolecules damage and an
increase in HSP72 and catalase in muscle biopsies from lifelong trained
individuals [177].
An increase in Nrf2 produced by exercise in the aged was proposed
as one of the different mechanisms by which healthy lifestyle and
dietary habits mediate the increase in longevity [23]. For instance, Nrf2
is proposed to be necessary for redox adaptations to exercise [181] and
as one of mediators of physical activity-promoted protection against
ROS-induced skeletal muscle damage [182]. Studies with knockout
mice for Nrf2 supported the role of this factor in mediating exercise-
induced antioxidant and functional actions in skeletal muscle
[183,184].
Nrf2 activation in response to exercise is not limited to skeletal
muscle level but also it occurs at the systemic level. In fact, exercise-
induced Nrf2-signaling in blood mononuclear cells has been demon-
strated to be impaired in older men [185]. Exercise also induces acti-
vation of Nrf2 in the cardiovascular system [186]. This is important
since Nrf2 down-regulation seems to be related to age-related vascular
dysfunction that improves after Nrf2 activation [187].
3.2. Inflammation
Low-grade chronic inflammation is one of the traits of the aging
process. Substantial evidence shows that aging is characterized by a
general increase in circulating levels and cell capability to produce pro-
inflammatory cytokines (e.g. interleukin IL-6, tumor necrosis factor
alpha (TNF-α), and C-reactive protein (CRP)). An increase in nuclear
factor κB (NF-κB) signaling and a reduction in anti-inflammatory cy-
tokines (e.g. interlukin 10, adiponectin, transforming growth factor- β)
may also characterize the aging process [188,189]. Chronic in-
flammation, in turn, plays a role in the development of age-related
diseases [112]. Moreover, elevated levels of pro-inflammatory cyto-
kines correlate with increased risk of morbidity and mortality among
the elderly, whether frail or not [23]. It is worth noting that several
processes trigger these inflammatory pathways, including age-asso-
ciated redox balance, senescence, and impaired autophagy [190].
Substantial evidence supports the relationship between chronic in-
flammation and physical performance in elderly subjects. Elevated le-
vels of different cytokines such as IL-6, TNF-α and CRP as well as white
blood cells (WBC) increase have been associated with poor function and
mobility status [191,192]. A recent population-based cross-sectional
study found an inverse and independent relationship between serum
CRP levels in old males and handgrip strength and physical perfor-
mance [193]. Likewise, abundant studies point to the association be-
tween IL-6 and frailty [194].
Again, how older people exercise matters. Acute bouts of exercise
induce an inflammatory response which elevate pro-inflammatory cy-
tokine levels which cause transient damage to contracting skeletal
Fig. 5. Aging process is associated with increased
reactive oxygen species (ROS) and inflammation
resulting in muscle dysfunction. Decreased levels
of insulin-like growth factor (IGF-1) are related to
aging with the subsequent diminished protein
synthesis and muscle growth via phosphatidyli-
nositol-3-kinase (PI3K)/AKT/mammalian target
of rapamycin (mTOR) pathway. Exercise may
exert potent anti-inflammatory and anti-oxidative
stress (i.e., through nuclear erythroid-2 like
factor-2 (Nrf-2) activation) effects and conse-
quently improve muscle function. In addition,
exercise increases protein synthesis via activation
of IGF-1 pathway and target myokines reducing
protein degradation. An increased signaling of the
transcription factor peroxisome proliferator-acti-
vated receptor γ coactivator-1α (PGC-1α) is also
induced by exercise, improving mitochondrial
function and reducing inflammation mediated by
nuclear factor κB (NF-κB).
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muscles [195]. Regular exercise, however, decreases the IL-6 and CRP
levels according to a recent meta-analysis [196]. Additionally, in-
creased levels of physical activity were also associated with higher le-
vels of the anti-inflammatory mediators adiponectin and interleukin 10
(IL10) in addition to the reduction of pro-inflammatory cytokines
[195].
Reduction in the expression of toll-like-receptor (TLR) on monocytes
is one of the potential mechanisms through which physical activity
brings about anti-inflammatory effects. Stewart and colleagues (2005)
found that 10–12 weeks of moderate exercise lowered TLR4 expression
and pro-inflammatory biomarkers in previously sedentary older parti-
cipants to levels similar to those observed in young individuals [197].
This evidence suggests that inflammation in older subjects is reversible
and, with the right intervention, it may be preventable [198].
It is worth noting that the effect of physical activity on in-
flammatory response varies by type, intensity, and frequency of the
exercise as well as on participant's characteristics [195]. Resistance
exercise appears to decrease TNF-α expression in aged skeletal muscle
which, in turn, may attenuate age-associated muscle changes [174].
Furthermore, older diabetic patients saw a reduction in their CRP
concentrations and an increase in adiponectin levels after 16 weeks of
resistance training [199]. A recent study has provided evidence that
aerobic exercise is more appropriate in modulating the immune system
and inflammatory markers among the elderly population than re-
sistance exercise [200]. Whereas there is overwhelming evidence
pointing to the anti-inflammatory effect that exercise has on older
people through its influence on cytokine levels, some studies have
failed to reach such favourable conclusion [201]. In neither frail nor
prefrail older adults did prolonged progressive resistance exercise
training affect IL-6, IL-8 and TNF-α circulating levels. Moreover, the
higher the levels of these markers the lower the strength gains were
during resistance exercise intervention [202].
It has been proposed that age-related inflammation of adipose tissue
is a key factor in skeletal muscle inflammation and muscle dysfunction
[203]. As aforementioned, insulin resistance is a condition associated
with physical impairment in the elderly. In fact, the relationship be-
tween insulin resistance and frailty could be mediated by inflammatory
processes as inflammation downregulates IGF-1 which affects muscular
regeneration [113]. In addition, inflammation causes insulin resistance
via the TNF receptor superfamily member 1A and the TLR-induced
activation of Janus kinase which, in turn, interferes with insulin sig-
naling. Concurrently, insulin resistance causes inflammation via central
obesity (adipocytes release the C-C motif chemokine 2 (CCL2)) and via
M1 macrophages tissue accumulation [113,204].
3.3. Autophagy
Autophagy is one of the multiple pathways by which cellular con-
tent is degraded. Autophagy plays a key role in maintaining skeletal
muscle homeostasis through the removal of damaged cell components
[205] Thus, autophagy-deficient mice mimic several age-related char-
acteristics including loss of muscle mass and quality [206] suggesting
the main role of this process is protecting against aged-related cellular
impairment. Evidence suggests that aging alters the autophagy process
present in skeletal muscle, thus, contributing to sarcopenia [207].
There are two main markers of this important process. One, lipidated
microtubule-associated protein 1 light chain 3 (LC3) II is often used as a
marker of the number of autophagosomes; and two, elevated LC3 II/
LC3I protein ratio in combination with decreased cargo protein Se-
questosome-1 (p62) levels may indicate increased autophagy [205]. An
increase, decrease, and non-change in LC3II/LC3I protein ratio have
been observed in aged skeletal muscle of various species [208]. Re-
cently, Aas and collaborators observed higher levels of LC3II, which
may indicate increased levels of phagosomes, in older participants,
across frailty status, compared to young participants, suggesting an age-
related process. On the other hand, they found higher levels of LC3I,
which may represent an attenuated phagosome formation, in frail old
compared to young individuals. Furthermore, LC3I negatively corre-
lated with specific strength. The correlations observed between specific
strength and some markers of autophagy indicates a possible link be-
tween these two factors [206].
Exercise impacts on the autophagy implicated in skeletal muscle
aging. Park and colleagues showed that activating autophagy through
physical activity increases muscle functioning and improves the sar-
copenic phenotype [209]. This could be related with the fact that in-
duction of chronic contractile activities in skeletal muscle cells recovers
LC3II levels and autophagy deficiency through decreasing oxidative
stress, resulting in improvement of mitochondrial function [210]. In
this sense, long term (34 weeks) voluntary resistance wheel exercise
initiated in middle-aged mice (15 month-olds) has been shown to in-
crease markers of mitochondrial density and activity and to increase
LC3II/I ratios. This was related to causing soleus hypertrophy and to
preventing sarcopenia in the hindlimb muscles of physically active aged
mice when compared to sedentary controls [211]. Meanwhile, in
human skeletal muscle, Dethlefsen and collaborators showed that age
and training status only modestly affected autophagic and apoptotic
markers. In this sense, a trend of higher LC3I, and LC3II levels were
observed in both trained and untrained elderly men [208]. Never-
theless, endurance exercise training has been shown to increase the
LC3II/LC3I ratio in skeletal muscle of aged rats [212] while lifelong
endurance exercise training seems to prevent the ratio's age-related
change in triceps muscle [213] and in humans' vastus lateralis [214].
These findings suggest that autophagy regulation is part of the meta-
bolic adaptation to exercise training.
In addition to chronic exercise, acute exercise also activates au-
tophagy and increases insulin sensitivity in skeletal muscle of older
mice [215]. However, recent studies indicate that exercise-activated
autophagy in skeletal muscle may depend on its intensity and duration
[209]. Therefore, evidence relating autophagy and exercise is incon-
sistent and requires further study.
3.4. Mitochondrial dysfunction
Mitochondrial dysfunction, including alterations in proteostasis,
biogenesis, dynamics, and mitophagy, is a key characteristic of aging
[216]. In fact, impaired mitochondrial function and biogenesis, when
observed in aged skeletal muscle, contributes to sarcopenia, poor
physical performance, and chronic fatigue [217,218]. Not surprisingly,
mitochondrial dysfunction seems to be a determinant factor in the as-
sociation of frailty with other age-related diseases [219]. Probably due
to the dysfunction's association to the highly prevalent age-related se-
dentarism which, in turn, is closely related to frailty and poor physical
performance [220].
Mitochondria are not only a source of, but also a target of, oxidative
stress resulting in mitochondrial dysfunction; thus, leading to a vicious
cycle. Recent work identified alleles in mitochondrial DNA associated
with unfavorable frailty and grip strength outcomes supporting the
clinical relevance of mitochondrial DNA alterations [23].
Skeletal muscles activate different redox-sensitive pathways as an
adaptive response to oxidative stress generated during contractile ac-
tivity. In this activity, NF-κB, MAPK, and the peroxisome proliferator-
activated receptor γ coactivator-1α (PGC-1α), seem to be the most re-
levant to exercise physiology. PGC-1α is considered the master reg-
ulator of mitochondrial integrity, function, and biogenesis. Reduced
PGC-1α in addition to an age-related lack of response mediated by this
factor has been previously reported [19,221]. In addition, and if we
take into account the implication of defective PGC-1α signaling in
sarcopenia and age-related skeletal muscle alterations, PGC-1α has the
potential of being a significant factor in the evolution of frailty phe-
notype [19].
Moreira and colleagues reviewed several studies reporting that
chronic endurance exercise, regardless of time and intensity, induces
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PGC-1α gene expression in the skeletal muscle in animal and older
human models [222]. Halling and collaborators provided evidence
using mice that physical activity protects against age-related mi-
tochondrial fragmentation in skeletal muscle by curbing mitochondrial
fission protein expression in a PGC-1α dependent manner [213]. These
findings support the important contribution of PGC-1α to the beneficial
effects of exercise training at advanced age by maintaining mitochon-
drial metabolic and antioxidant capacity [223].
As discussed above, Nrf2 activation is key for adaptive antioxidant
defense in response to exercise. In addition to its effects on oxidative
damage, exercise-induced Nrf2 activation may exert beneficial effects
on muscle performance by improving mitochondrial biogenesis and
function [167–169,224].
On the other hand, central to the maintenance of a healthy mi-
tochondrial pool is the removal of dysfunctional organelles via mito-
phagy. Despite scarce data on how mitophagy is impacted by growing
older and chronic exercise [225], mitophagy dysregulation has been
denoted as a major pathogenic mechanism in muscle wasting [226]. In
fact, reduced protein levels of LC3 II and Atg7 have been detected in
muscle biopsies of older individuals [227]. Therefore, exercise-induced
mitophagy might benefit aged muscle by preventing the accumulation
of damaged mitochondria. Supporting this, 6-month weight loss in
combination with a moderate intensity exercise program was reported
to increase mRNA expression of LC3II, Atg, and lysosome-associated
membrane protein 2 (LAMP-2) in the vastus lateralis of elderly over-
weight women [228]. Furthermore, lifelong exercise may preserve the
expression of LC3II and Atg at the same levels as those observed in
young controls [228].
3.5. IGF1/mTOR
As we age, insulin/IGF-1 signaling is impaired, mainly due to insulin
resistance and lowered IGF-1 levels, with the subsequent diminished
protein synthesis and muscle growth via phosphatidylinositol-3-kinase
(PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway [23].
Previous work has reported an association between IGF-1 and frailty.
Doi and colleagues concluded that lower serum IGF-1 levels were in-
dependently related to frailty in older adults [229]. Further, IGF-1 le-
vels were lower in individuals with frail/low relative appendicular
skeletal muscle mass (RASM) compared to their frail/normal RASM
peers. IGF-1 levels were significantly associated with frail/low RASM
status for the overall cohort [230].
Insulin-like growth factor cell signaling pathway, involving PI3K,
AKT and mTOR, is crucial for post-exercise protein synthesis increase
[221]. mTOR is one of the major pathways modulated by exercise, al-
though different data indicated that the outcome varies depending on
the type of training [231]. For instance, strength training activates IGF-
1 and the mTOR pathway is stimulated resulting in muscle protein
synthesis through mRNA translation and ribosomal biogenesis. The
impact of aerobic exercise varies by age, however. In young animals,
with a lower cell energy state, AMPK is activated, mTOR is inhibited,
and PGC-1α is activated leading to mitochondrial biogenesis [232].
Among old animals, mitochondrial biogenesis activation by aerobic
exercise is somehow inhibited [221].
In addition, studies involving resistance type of exercise have
usually reported a weaker anabolic protein response in older in-
dividuals when compared to younger ones as a consequence of
mTORC1 signalling pathway dysregulation. This may be indicative of
the presence of higher levels of cellular stress markers in older in-
dividuals which, in turn, may impact the post-exercise remodeling re-
sponses [221].
It is worth underscoring that regular exercise augments skeletal
muscle mass by increasing glucose levels. Higher glucose levels boost
insulin action resulting in improved insulin resistance [233]. Further-
more, a recent study reported that a 12-week combined anaerobic and
aerobic exercise program may improve insulin resistance, IGF-1,
growth hormone (GH), and DHEA-S levels in elderly Korean women
[234].
3.6. Myokines
Myokines are molecules, cytokines or signaling peptides (e.g., IL-6,
IGF-1, irisin, myostatin, IL-15, fibroblast growth factor 21) expressed,
synthesized, and released by skeletal myocytes in response to muscle
contractions with pluripotent effects [235]. The expression of some of
these myokines may vary with age in rodents and humans. Some such
as apelin [236] may decline, some may remain unchanged such as
myostatin, and still others may increase such as GDF-11 (a member of
transforming growth factor TGF-β signaling pathway) [237].
Moreover, myokines seem to affect multiple processes associated
with physical frailty, including muscle wasting, dynapenia, and slow-
ness [238].
A recent review has reported that the benefits of exercise include
estimulating a healthy anti-inflammatory environment, mainly via the
release of muscle-derived myokines, and reducing age-related loss of
muscle mass and function [239]. In humans, an increase in systemic
concentration of decorin has been reported after acute and chronic
exercise [240]. This myokine seems to play a role in inactivating
myostatin, a known negative regulator of muscle mass, resulting in
decreased muscle protein degradation [241]. The level of circulating
irisin increased and presented a positive correlation with both grip and
leg strength after an exercise program [242]. Apelin is another exercise-
induced myokine reported to be involved in neutralizing age-associated
muscle wasting [236]. Muscle wasting is offset by inducing mitochon-
driogenesis, fostering muscle's regenerative capacity, and mitigating
muscle-related inflammation [237].
It is worth mentioning that myokines are likely to play an important
role in whole body homeostasis. Thus, the shifts in their production/
synthesis/downstream signaling may play a role in the onset of certain
metabolic, cardiovascular, and kidney diseases among others [238].
This multisystemic effect, also attributable to the other mentioned
signaling pathways, may contribute to the positive impact of physical
activity on frailty, especially taking into account that this frailty results
from a multisystemic dysfunction (Fig. 6).
4. Exercise training interventions
Several types of exercise programs have been described [243].
Every kind of intervention has its own characteristics and expected
effects on skeletal muscle and function, as well as on other body sys-
tems.
4.1. Physical exercise
Physical activity is defined as any body movement produced by the
skeletal system that increases energy expenditure. Physical exercise is
physical activity carried out with a structured frequency and whose
objective is to maintain or improve some component of an individual's
physical fitness (muscular strength, flexibility, balance or cardiovas-
cular endurance) [243]. Specificity is the fundamental principle of
physical exercise. Hence, in order to generate muscular, cardior-
espiratory, and central system adaptations, an exercise program that
works on all these components should be proposed. When several
adaptations are needed, as in the case of frail/prefrail people, multi-
component exercise programs have been proposed as the most effective
option [244,245].
The effectiveness of all these programs has been largely established
(Table 1), although the ideal composition of the physical exercise
program remains elusive [255]. Exercise training must be prescribed as
a treatment for age-related frailty [256] and, like any treatment, must
be adjusted to the right dose. Physical exercise prescribers must in-
crease (or decrease) the dose based on individual progress. Prescribers
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should combine the main variables in training (duration, type, intensity
and frequency) until they find the optimal dose for each individual. The
goal should be to establish an evidence-based and feasible exercise
protocol to be implemented in the clinic.
4.2. Aerobic exercise
Aerobic capacity, i.e., the heart and lungs ability to oxygenate
muscles, has been strongly associated with mortality, CVD, mobility
limitations, and disability [58]. Aerobic capacity is usually measured
via VO2 maximum or peak. After the third decade of age, this capacity
progressively declines, decreasing the ability to perform activities of
daily living (ADLs). One of the most notable effects of endurance
training is on increasing VO2 peak, an important determinant of frailty
in older adults [257]. Moreover, as the muscle adapts to endurance
exercise training, its oxidative capacity increases resulting in higher
fatigue resistance or increased muscle endurance [246].
Several ways of assessing cardiopulmonary condition are currently
available. Based on exercise gas exchange variables, cardiopulmonary
exercise testing (CPET) is the best evaluation tool for determining ex-
ercise intolerance, or dyspnea on exercise, and estimating the cardior-
espiratory fitness. Despite being limited by the setting and by the ex-
pensive equipment required, CPET is most commonly used for disease
management such as heart failure and pulmonary hypertension.
Further, it has potential diagnostic utility for older adults with decline
in exercise levels [258].
Two of the conventional submaximal exercise tests commonly used
in elderly as a measure of walking speed and mobility performance are
the 6-min walking test and the 400 m walking test. These tests only
require a long corridor (≥30 m recommended) and a stopwatch.
Additionally, the placement of chairs along the corridor and having a
trained professional walk closely behind the patient are suggested. In
addition, the 400 m test has been shown as a prognostic factor and a
predictor for CVD, mobility limitation, and mobility disability in older
persons reporting no walking difficulties [58]. Additional, valid mea-
sures of health outcomes using shorter distances have been established.
A well-validated protocol entails a 4 m course from a standing start
[259]. A gait speed of at least 1.4 m/s indicates patients are likely to be
able to perform their ADLs independently, whereas a gait speed of<
0.8 m/s suggests patients are likely to be frail, to be at increased risk of
falls, and to be dependent regarding their ADLs and their Instrumental
Activities of Daily Living (IADLs) [260].
Guidelines from the American College of Sports Medicine and the
American Heart Association for older adults recommend a minimum of
150 min per week of moderate intensity aerobic training (30 min on
five out of seven days per week) or a minimum of 60 min (20 min on
three days per week) of vigorous activity [261]. Although frail in-
dividuals may not be able to meet this recommendation, modest in-
creases in activity and strenghtening exercise could impact positively in
the progression of functional improvement [246,262].
Many activities have been proposed for increasing aerobic capacity
such as brisk walking, jogging, water aerobics, swimming, dancing, or
bicycle riding. In addition to these classical approaches, a recent paper
has shown benefits after implementing a High Interval Intensity
Training- HIIT program [252]. Among them, walking is the easiest,
cheapest, most feasible, most relevant to ADLs, and the easiest to be
assessed in the clinic. Although there are different approaches ac-
cording to the functional status of the person [253,263,264] there are
not standardized and generally accepted rules about the prescription of
aerobic exercise to frail people.
4.3. Strength exercise
Muscle strength is the force or tension that a muscle or muscle group
generates [265]. The extent of muscle strength loss with age, inactivity,
injury, and immobilization depends on impaired neuromuscular acti-
vation and reduced muscle volumen [266]. Strength workout seems to
be the key element in preventing sarcopenia and falls, while keeping
functional capacity [249,267], also in older people [246].
There are some well-validated techniques to measure muscle
strength. Handgrip strength (on dominant arm) is the most common,
and it is used in research and clinical settings. The most common dy-
namometer used for this test is JAMAR Hydraulic Hand Dynamometer.
Test should be repeated ideally twice, recording the best one [268].
In order to measure intensity (percentage of the maximal strength
that an individual can develop), the one-repetition maximum (1-RM) is
commonly used. It is defined as the maximal weight an individual can
lift for just one repetition with correct technique, and it is considered
the gold standard for assessing muscle strength [269]. Depending on
the intensity, strength training should be prescribed every other day,
Fig. 6. Physical activity/exercise training may
influence the outcome of the aging process by
modulating key signaling pathways. Exercising
results in reduced age-related oxidative damage,
reduced chronic inflammation, increased autop-
hagy, improved mitochondrial function, improved
myokine profile, augmented insulin-like growth
factor-1 (IGF-1) signaling, and insulin sensitivity.
These actions promote beneficial effects on ske-
letal muscle (muscle mass, strength, and function)
but also at systemic level, inducing improvements
in function of cardiovascular, respiratory and
metabolic systems. Exercise-induced improve-
ments in muscle function as well as systemic
benefits and age-related chronic diseases allevia-
tion are all related to the improvements in phy-
sical function and frailty improvement by ex-
ercise/physical activity.
J. Angulo, et al. Redox Biology 35 (2020) 101513
10
Table 1
Study findings of the effect of physical exercise interventions on physical function in older people across frailty status.
Author, year Sample Intervention Main findings






10 weeks MCI (3 types: ET, multinutrient
supplementation, or both (group B))
• ET improved muscle strength• All training methods improved gait speed and muscle
mass and both declined in non-exercisers
• Stair climbers power improve vs non exercisers• The group B gained weight compared with ET or
multinutrient group




24 weeks MCI (aerobic, strength, balance and
flexibility)
• Improved SPPB and 400 m test vs control






12 months multifactorial individually according the
Fried criteria met:
If weight loss, a dietician evaluated nutritional intake
If exhaustion and Geriatric Depression Scale score was
high, study team considered referral to a psychologist or
psychiatrist
If weakness, slowness or low energy expenditure,
patient received 10 home-based physiotherapy sessions
• Intervention improved SPPB vs control• Intervention significantly decreased frailty at 12
months but not at 3
Cadore et al., 2014 [249] 24 older adults




12 weeks MCI (muscle power training, balance and gait
retrain)
• Intervention improved TUG with single and dual
tasks, rise from a chair, balance performance, and
reduced incidence of falls.
• Intervention enhanced muscle power and strength
Pahor et al., 2014 [21] 818 older adults
70 - 89 year-olds
Community-dwellers
• Structured, moderate-intensity physical activity
program conducted in a centre (twice/wk) and at
home (3–4 times/wk): aerobic, resistance, and
flexibility training activities.
• Or a health education program: workshops on topics
relevant to older adults and upper extremity
stretching exercises
• Reduced major mobility disability over 2.6 years
among older adults at risk for disability vs health
education program
Kwon et al., 2015 [250] 89 older adults
Prefrail (Fried criteria, although
considered frail if met 2 criteria
at the time of enrolment)
65–91 year-olds
Community-dwellers
12 weeks. Three groups: one MCI (Warm-up, strength
training, balance training and cool-down), MCI plus
nutritional program (cooking class) (MCI-NP); and
control
• MCI improve handgrip strength, but effect was not
maintained at 6-month postintervention
• MCI-NP and control did not obtained significant
changes in measures of physical performance.
However, handgrip strength declined
postintervention and follow-up in the MCI-NP group
Tarazona-Santabalbina
et al., 2016 [251]




• MCI (proprioception, aerobic, strength, and
stretching exercises for 65 min, 5 days per week, 24
weeks).
• Control group
• Reverses frailty and improves functional
measurements: Barthel, Lawton and Brody, Tinetti,
Short Physical Performance Battery and physical
performance
• Improves cognitive, emotional, and social networking
determinations: Mini-Mental State Examination,
geriatric depression scale from Yesavage, EuroQol
quality-of-life scale
• Decreases the number of visits to primary care
physician
• Significant improvement in frailty biomarkers.
Vs control group
Losa-Reyna et al., 2019
[252]




• Six weeks MCI (Power training and HIIT)• Usual care •
Reduction Frailty Phenotype
• Improvements in SPPB, muscle power, muscle






• In-hospital MCI included individualized moderate-
intensity resistance, balance, and walking exercises
(2 daily sessions)
• Usual care
• Increased the SPPB scale and Barthel Index score
over the usual-care group
• Reversed functional decline• Significant intervention benefits at the cognitive level
over the usual-care group
Rodríguez-Mañas et al.
et al., 2019 [22]
964 prefrail and frail older




• Multimodal intervention individualized and
progressive resistance exercise programme for 16
weeks plus a nutritional educational program over
seven sessions plus Investigator-standardized
training to ensure optimal diabetes care
• Usual care
• After 12 months: Improvement in SPPB scores vs
usual care
• Cost-effective improvement in the functional status of
older frail and prefrail participants with type 2
diabetes mellitus. Vs usual care




• 12-week MCI (resistance and aerobic exercises,
cognitive training, board game activities)
• Wait-list control group
• Reduction in the combined frailty score• Improvements in muscle endurance, balance, verbal
fluency, attention and memory, executive function,
and self-rated health vs control group
ET: Exercise Training; HIIT: High Interval Intensity Training; MCI: Multicomponent Intervention; MCI-NP: Multicomponent Intervention plus Nutritional Program;
SPPB: Short Physical Performance Battery; TUG: Timed Up and Go.
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especially in the initial workout stages [270]. Simple instructions
should be provided, and both haptic support and mirror techniques are
recommended [271].
4.4. Power exercise
Musculoskeletal power can be defined as the product of the force of
a muscular contraction and its velocity. After the age of 50, around 3%
of muscle power is lost every year, three times faster than strength
[272]. Leg power is highly related to physical performance in older
people [273].
Muscle power can be measured in any exercise or movement. Mostly
common muscle lower exercises, leg press and knee extension, show
good reliability and validity [274]. The 5 times sit-to-stand (5STS) test
is an easy and inexpensive procedure in which only a chair and a
stopwatch are required. It has shown to be a valid, clinically relevant
tool [275].
Power training intensity should range from 30% to 60% of 1-RM
load because maximal power output is maximized at these intensities
[276]. Participants should perform concentric (shortening) phase ex-
ercises as fast as possible.
Power training should be prioritized in elderly, because it improves
gait speed, chair stand test and stair climb time [270]. In a recent meta-
analysis, high speed training resulted in improvements in the Short
Physical Performance Battery (SPPB), although not in other functional
capacity tools [270]. Furthermore, lower training volumes have been
reported to be associated with greater improvements in muscle power
[277].
4.5. Flexibility exercise
Flexibility is the range of motion (ROM) of one or several joints.
Flexibility is scarcely measured in studies, and no scale has achieved
wide acceptance. Probably, measuring flexibility with a goniometer on
each specific joint could be the best option to assess ROM changes. A
stretching or flexibility program is aimed at greater ROM by rising both
static and dynamic stretching tolerance [278]. Static stretching refers to
the ability to maintain the position at the end of the ROM. Dynamic
stretching refers to achieving, on a repeated gradual transition on any
part of the body, a progressive increase in ROM [279]. Dynamic
stretching can be included in warm-up [266], whereas static stretching
exercises could be performed at the end, as part of the cool-down phase
[278].
4.6. Balance exercise
Neuromuscular systems, sensory systems (i.e., vestibular, visual,
somatosensory) and cognitive systems (i.e., cerebellum, hippocampus,
prefrontal and parietal cortices) have an important role in balance.
With aging, all these systems deteriorate, increasing the risk of falling
[280]. Inter-joint coordination and the appropriate timing of muscle
action is also affected.
Berg Balance test is probably the most common test to evaluate
balance in the elderly, assessing risk for falls in older community-
dwelling adults through direct observation of their performance [281].
However, this test is time-consuming and balance assessment by SPPB
is much faster, representing a more convenient tool for clinical practice.
There is evidence showing that balance and functional exercises
reduce the rate of falls by 24% and by 13% the number of older people
who experience one or more falls. Moreover, multi-component exercise
programs (balance and functional exercises plus resistance exercises)
reduce the rate of falls by 34% and by 22% the number of people ex-
periencing one or more falls [282]. Further, supervised balance exercise
programs seem to get better results than unsupervised ones [283].
Balance exercises are recommended three days per week, with at least
two of them being supervised. Both dynamic and static exercises should
be performed [283]. Patients with poor scores in the progressive
Romberg test of the SPPB could benefit from a higher frequency of
balance training [284].
There are many exercises to improve balance depending on which
system (sensory, cognitive, or musculoskeletal system) needs to be
worked on. They include single leg stances, semi-tandem and tandem
stance, toe walking, heel walking, tandem gait, walking on a balance
board, and eye-hand or eye-leg coordination. The possibility of making
each of them with open or closed eyes, joining the arms to the body or
opening them, doing them on unstable surfaces or adding cognitive
components such as specific orders, music or dual-task exercise, makes
it almost impossible to monitor the workload. The program should in-
clude static vs. dynamic task, changes in the base of support, variations
in the center of gravity height, and distinct standing surfaces [280].
Exercise difficulty should progressively increase involving both motor
and cognitive tasks (dual- and multi-task activities) [280].
4.7. Non-physical training exercises
Recently Marusic and Grosprêtre reviewed one of the proposed
tools, the non-physical training exercises, to improve balance and
strength in older people, including those who are frail. These exercises
include activities such as motor imagery (MI) and action observation
(AO) [285,286]. These tools have been gaining relevance because
normal aging is also associated with a progressive reduction in central
and peripheral neural function. MI stands for the mental simulation of
an action without any corresponding motor output, but still causing
neuronal activation [286]. Meanwhile, AO, a tool grounded in basic
neuroscience and the mirror neuron system [287], has been proposed to
intensify neural activation induced by mental practice [286]. These
types of interventions are deemed safe and efficient and do not add
additional neuromuscular fatigue when incorporated into any type of
intervention, something relevant in frail people [286]. Although the
results are very promising, their effectiveness is still awaiting sup-
porting evidence.
4.8. Adherence
The best physical exercise is the one that is actually carried out.
Adherence rates to exercise programs are usually suboptimal, although
comparisons across studies are often hampered due to differences in
reporting [288]. Adherence may be improved by following certain tips.
Before starting the exercise program, patients must be informed about
the possible risks and benefits of the exercise program. A clear de-
scription of the program may increase motivation and adherence [289].
In addition, physical exercise professionals must inform about the im-
portance of physical exercise in physical functioning, well-being, and
quality of life [290], and attend to patient preferences and acceptance
[291]. It is also desirable to create a friendly and familiar training at-
mosphere with the patients and; finally, the proper execution of the
exercises must be closely monitored [271].
Other barriers to overcome are socioeconomic factors. Participation
in exercise programs may be reduced by lack of transportation, fixed
incomes, or inclement weather [292]. Thus, although supervised ex-
ercise programs seem to have better results in terms of strength and
balance [283], home exercises [293] or video games-based interven-
tions [294] could be a good option for some patients. Notwithstanding,
as the impact of social isolation on frailty is well established, group
exercise enjoys the additional benefit of socialization [295].
4.9. Adverse events
In contrast to the usual risks associated with poli-pharmacy, phy-
sical exercise administration is safe, relatively free of potential un-
wanted side effects [296], and adverse events are rare [297]. The use of
a multidisciplinary team (e.g., geriatricians, nurses, physiotherapists)
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seems to be the best option in order to avoid unnecessary risks, espe-
cially regarding the most vulnerable participants.
4.10. Adapting exercise intervention to individual functional status
4.10.1. Robust subjects
Older people who perform more than 180 min of weekly exercise
report better health-related quality of life [298]. A substantial increase
in physical activity level regardless of the baseline level (i.e., from se-
dentarism to moderate activity or from moderate to vigorous activity)
has been associated with a reduction in sarcopenia prevalence and
better performance of muscle mass and function [299]. More specifi-
cally, strength training seems fundamental, since decline in strength
levels in older adults compromises overall function and it is predictive
of future functional decline and higher incidence of frailty, disability,
and mortality [58,300].
4.10.2. Prefrail older adults
The population of prefail adults is one of the main targets of exercise
interventions since it includes between 35% and 50% of individuals
over 65 [108,301] and it is the subpopulation most likely to benefit
from an exercise program [302]. Again, strength training is key since
muscle weakness seems to be the most prevalent of the Fried compo-
nents of frailty among the prefrail [303,304]. Kwon et al. reported that
with just one weekly training, prefrail women could improve their
strength. However, one day a week was not enough to achieve im-
provements in physical function, and any improvements in strength
were lost three months after the end of the intervention [250]. In
support of more frequent training, the MID-FRAIL study, which in-
cluded pre-frail older people with type 2 diabetes mellitus participating
in a multimodal intervention (detailed description of the study is pro-
vided below), reported improvements in functioning (as assessed by
SPPB) among those participating in a strength training program twice
weekly for 16 weeks [22].
4.10.3. Frail patients
Several training programs in different care settings (ambulatory or
in-hospital) have been designed for frail people. A well-designed mul-
ticomponent exercise program showed improvements in gait speed,
balance, SPPB functioning scores, ADL performance, as well as in frailty
status [251]. The program was more intensive than most. It included a
high training frequency (5 days per week) and relatively long sessions
(65 min each). The intervention included strength exercises with elastic
bands, stretching, and aerobic exercises including walking, arm move-
ments and stair climbing. Attendance of at least 50% of the pro-
grammed sessions was associated with a substantially higher likelihood
of reversing frailty to the point of robustness [251]. There is also evi-
dence of improvements in leg strength and in SPPB functioning score
obtained with a two-day/week supervised lower and upper body
strength training program. Further, greater gains in muscle mass were
obtained in the group receiving protein supplements [305,306].
Results from the “Sarcopenia and Physical fRailty IN older people:
multi-componenT
Treatment strategies (SPRINTT)” study are expected to clarify the
association between physical exercise and physical frailty and their
relationship with sarcopenia. This randomized controlled trial follows
1500 community dwelling older persons aged 70 years and older with
sarcopenia and physical function impairment (SPPB ≤ 9) for up to 36
months. The efficacy of a MultiComponent Intervention (MCI), based
on long-term planned exercise program and dietary guidance /inter-
vention for preventing mobility disability is tested in comparison with a
Healthy Aging Lifestyle Education (HALE) [307].
Among the many comorbidities present in frail and prefrail in-
dividuals, one of the most common is diabetes. In the MID-Frail study,
964 frail and prefrail elderly with diabetes were included according to
the Fried phenotype. In this study, the effect of a three-pronged
intervention, including a resistance exercise program, a nutritional and
educational program, and a standardized across sites researcher-en-
hanced training for best practices in diabetes care, was compared with a
usual care group. The physical exercise intervention was a supervised
individualized resistance exercise program consisting of a 2-week pre-
training and learning phase followed by a 16-week program with par-
ticipants undergoing two 45-min exercise sessions per week. Selected
exercises were leg presses and bilateral knee extensions carried out in
two to three sets of 8–10 repetitions each with a load equivalent to
40–80% of 1-RM. The intervention not only improved the functional
capacity of the treatment group compared to the usual care group but
also it proved to be cost-efficient with average savings of 428.02 euros
per participant per year [22].
A recent systematic review found strength muscle improvements in
frail older adults with very different protocols [308]. Training fre-
quencies ranged from 1 to 6 times per week, including from 1 to 3
exercise series, and series including from 6 to 15 repetitions. Intensity
was controlled by the rate of perceived effort (RPE) or by the percen-
tage of 1-RM (from 30 to 100%). The review reported several findings.
The main ones being that strength exercise, either performed in isola-
tion or in combination with other training modalities, did improve
muscle mass, strength and power, and/or functional capacity (not all
studies saw improvements in all aspects). It is worth mentioning that
using RPE to control exercise intensity was associated with no muscle
strength improvement, suggesting that RPE underestimates exercise-
related effort in this population of individuals.
4.10.4. Hospitalized older adults
Being immobilized, a usual condition in institutionalized and hos-
pitalized older people [309], reduces muscle mass by 0.5% and muscle
strength by 0.3–4.2% per day [310]. These losses often result in a sig-
nificant deterioration in functional status with the corresponding de-
cline in quality of life [311].
Improving the functional capacity of hospitalized oldest old patients
through an MCI has proven feasible [253]. Due to the high levels of
sedentarism these patients present, high frequency interventions (i.e., 2
daily exercise sessions for 5–7 consecutive days) seem to have better
results than lower intensity interventions. The first session of the day
was supervised, lasted about 20 min, and included balance, gait re-
training, and resistance exercise. The second one was unsupervised and
consisted of strenght exercises using 0.5–1.0 kg anklets and a handgrip
ball. This intervention improved SPPB score, Barthel Index, and cog-
nition [253].
Different strategies have been proposed to succesfully improve
strength in these patients [312]. Nevertheless, resistance training seems
to be the best exercise to improve strength and other outcomes, such as
muscle mass, neural impulse, or mitigated bone loss. The effects of
resistance training could be optimized if combined with vibration
(general or local), blood flow restriction, and especially with neuro-
muscular electrical stimulation [312,313] Restriction of blood flow and
vibration can be combined with aerobic training and with low intensity
strength training (< 20%), having special relevance in situations where
high intensity exercise is not possible.
4.11. From research to clinical setting
Due to the heterogeneity of the population of older adults, there is a
lack of consensus regarding a gold standard measure of functional ca-
pacity. This, combined with the differences among exercise programs,
makes the translating of results from research settings to clinical
practice difficult to say the least.
Numerous scales and tools have been tested as measures for physical
capabilities of older adults and to detect clinically significant changes.
Subjective scales are important to epidemiologic and qualitative re-
search, as well as for learning what patients feel or think about their
household or recreational activity functional level.
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However, objective scales are more sensitive to changes, and can be
standardized and reproduced. For instance, gait speed is a key element
in the physical independence of a person and, thus, frailty, and, con-
sequently, it has been repeatedly evaluated in different clinical settings.
Another test used and validated to evaluate physical function in
older adults is the SPPB [314]. In addition to assessing gait speed at the
individual's usual pace, this test measures balance (using the Romberg
progressive test) and strength in lower limbs (with the 5STS test). The
SPPB has been correlated with ADLs loss [315] and it is a good tool to
identify patients who may benefit from an exercise intervention [302].
The prescription of different physical exercise programs in frail and
prefrail patients based on the baseline physical performance of the
patient is becoming a well-established strategy. Although the main
evidence comes from the SPPB-based prescription, other instruments to
assess frailty status, like the Frailty Trait Scale (FTS) [316] or its short-
form FTS5 [317], could be theoretically used for the same purpose
[248].
In the LIFE study, the prescription of physical activity-based inter-
ventions depending upon the SPPB score improved subsequent health
outcomes [21,247,314]. Similarly, exercise prescription based on
functional capacity as revealed by SPPB score could be optimal for
using in physical exercise programs such as Vivifrail [263].
Using this approach may improve the prescription of physical ex-
ercise programs, thus optimizing their effects in the following ways
(Fig. 7):
1 Emphasizing strength interventions could be useful in those patients
who have low knee strength, low grip strength, and poor 5STS as
well as people with higher scores in the Brachial/Ankle Index (BAI)
which could be compatible with peripheral artery disease [318].
2 Emphasizing power interventions for patients with low gait speed,
poor 5STS and balance test scores.
3 Emphasizing balance intervention for patients with low Romberg
progressive test scores.
4 Verbal fluency could be improved with dual tasks and strength
training [249] and multicomponent exercise programs [254,319].
5 Emphasizing aerobic training in patients with sedentary behavior,
low gait speed, or low physical condition. It could be also re-
commended in patients with higher BAI scores [320].
Additional research is needed to further contribute to our knowl-
edge about the optimal dose of individually fitted exercise programs by
frailty status. In fact, not prescribing exercise programs to older po-
pulations may be considered unethical, in light of the substantial evi-
dence showing health benefits [321]. Finally, evidence-based effective
physical exercise intervention protocols should be translated to clinical
practice.
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